RFI for Compounding Pharmacy Services

The government authority in California seeks licensed compounding pharmacies to provide sterile intramuscular (IM) compound clozapine across a statewide hospital system for market research purposes. The selected vendor must establish a secure, temperature-controlled distribution chain to deliver the compounded medications reliably. Additionally, the vendor must implement a comprehensive quality management system that includes routine environmental monitoring, potency testing, batch sterility assurance, and full process documentation. The buyer requires complete compounding transparency, including batch records, certificates of analysis, and clear supply chain communication regarding lead times. Only United States organizations are eligible to participate, and the vendor will perform all work offsite. Interested bidders must submit all questions by September 16, 2026. Bidders may submit their responses digitally via email or online, and the buyer is looking for a proposal regarding the budget.